Skip to content
CareDx At ATC 2020 Banner

You’re Invited to CareDx’s Virtual Transplant Events – 2020

CareDx hosted a series of virtual events between May 28 and June 2 to share the latest clinical data featuring CareDx technologies – AlloSure, AlloMap, KidneyCare, HeartCare, and iBox. Watch the virtual symposium, virtual abstract sessions, and a CareDx hosted panel on the future of telemedicine with the CEO of doxy.me.

On-Demand

Thursday, May 28

Virtual Abstracts Session

12:00 pm – 1:00 pm PDT / 3:00 pm – 4:00 pm EDT
Characterization of An Integrative Prognostic Score for US Patients Taken From the Dart Study

– Abdolreza Haririan, MD, Maryland

Abdolreza Haririan, MD Maryland
Donor-derived Cell-free DNA For Detection of Cell-mediated Rejection In Low Risk Kidney Transplant Patients

– Sanjiv Anand, MD, MS-Intermountain Medical Center

Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-derived Cell-free DNA

– Kalathil Sureshkumar, MD, Allegheny

Center Experience with dd-cfDNA in Lung Transplantation

– Deborah Jo Levine, MD, UT Health San Antonio

Deborah Jo Levine, MD

CareDx Transplant Cares Celebration

3:00 pm – 3:30 pm PDT / 6:00 pm – 6:30 pm EDT


Live performances from some of your talented colleagues and patients.


Star Performers
Dory S
Dorry Segev, MD, PhD

- Johns Hopkins

Hector Ventura, MD

- Ochsner Health

Angelica Hale
Angelica Hale

- Kidney Transplant Recipient
Americas Got Talent - Runner up

Mark Lopez and the SA PainKillerz Band

- Methodist Hospital

Friday, May 29

CareDx Virtual Symposium

12:00 pm – 1:00 pm PDT / 3:00 pm – 4:00 pm EDT
Symposium Chair

– Manikkam Suthanthiran, MD,  Weill Cornell Medicine

Manikkam Suthanthiran, MD, Cornell
AlloSure Differentiating Ambiguous Rejection
– Nicolae Leca, MD University of Washington
Nicolae Leca, MD University of Washington
COVID-19 in Transplant: By the Numbers

– Hannah A. Valantine, MD – NIH

Hannah Valentine, MD
Telehealth in Transplant: The New Reality
– Marlon Levy, MD, VCU
Marlon Levy, MD
Center Cases Leading to Change in Practice​
– Robert Stratta, MD, Wake Forest
Robert Stratta, MD, Wake Forest
– Stan Jordan, MD, Cedars Sinai
Stan Jordan, MD, Cedars Sinai

– George Burke, MD, Jackson Memorial

George Burke, MD, Jackson Memorial

CareDx Company Press Conference at American Transplant Congress

2:00 pm – 2:45 pm PDT / 5:00 pm – 5:45 pm EDT
Innovation in
Allo-Transplantation
 

Peter Maag, PhD, CEO and Chairman CareDx

Peter Maag, PhD
Deep Sequencing Data: Clinical Relevance

Medhat Askar, MD, PhD, Director, Transplant Immunology & COVID-19 Testing, Facility Director, Cell Processing Laboratory, Baylor University Medical Center, Professor, Department of Pathology and Laboratory Medicine, Texas A&M Health Science Center College of Medicine

Medhat Askar, MD, PhD
Digital: Predicting and Connecting

Alexandre Loupy, MD, PhD, Head of the Paris Expertise Centre for Organ Transplantation in PARCC U970, Professor of Nephrology and Epidemiology, Kidney Transplant Department, Necker Hospital, Paris, France

Alexandre Loupy, MD, PhD
Multimodality: Patient Reality

David Guthrie, Chief Product Officer Patient Point, Ex-CTO of WebMD and lung transplant recipient

David Guthrie

Tuesday, June 2

Future of Telemedicine and COVID Insights

The CEO of Doxy.me will moderate a panel of transplant clinicians and patients on their recent experiences with telemedicine
10:00 am – 11:00 am PDT / 1:00 pm – 2:00 pm EDT

– Dr. Brandon Welch, CEO – Doxy.me

Brandon Welch, CEO – Doxy.me


Virtual Abstract Session

12:00 pm – 1:00 pm PDT / 3:00 pm – 4:00 pm EDT

The Use of AlloSure Donor Derived Cell-free DNA in a Community Based Kidney Transplant Program

– Velma P. Scantlebury, MD – ChristianaCare

Utility of dd-cfDNA in TCMR 1A and Borderline Allograft Rejection

– Erik Stites, MD, UCHealth

Peds Post Rejection Treatment, Biopsy Proven (Both T Cell And B Cell). Looking at AlloSure 3 Months Post, Along with AT1R and DSA

– Dechu Puliyanda, MD, Cedars

Utility Of Donor Derived Cell Free DNA For Detecting Allograft Rejection With PD-1 Checkpoint Inhibitor Use

– Dan Brennan, MD, Johns Hopkins

Value of dd-cfDNA When Considering Recipient Ethnicity to Further Help Risk Stratify Transplant Recipients

– Anthony Langone, MD, Vanderbilt

Anthony Langone, MD, Vanderbilt

CareDx virtual events are not part of the ATC official educational program and the sessions are not endorsed by ATC.